Product image of Ivermectina Difa (Ivermectin) supplied by GNH India

Ivermectina Difa

Active Ingredient:
Ivermectin
Origin:
EU

Ivermectina Difa (Ivermectin)

Ivermectin, the active ingredient in Ivermectina Difa, is an antiparasitic presented as an oral formulation for systemic use. It treats a range of parasitic infections such as onchocerciasis, strongyloidiasis, scabies, pediculosis and other helminthic diseases in adults and children when prescribed by a qualified health professional.

GNH India supplies Ivermectina Difa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Difa Cooper S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ivermectina Difa belongs to the antiparasitic drug class and is used to treat infections caused by nematodes and ectoparasites.

  • Onchocerciasis: reduces microfilarial load and prevents disease progression.
  • Strongyloidiasis: eradicates intestinal larvae and prevents chronic infection.
  • Scabies: eliminates Sarcoptes scabiei mites, relieving skin lesions.
  • Pediculosis: kills lice and nits, controlling infestation.
  • Other helminth infections: broad‑spectrum activity against various intestinal worms.

How It Works

  • Ivermectin binds to glutamate‑gated chloride channels that are present only in invertebrate nerve and muscle cells. Activation of these channels increases chloride ion influx, causing hyperpolarization of the cell membrane, leading to paralysis and death of the parasite without affecting mammalian cells.

Side Effects

Ivermectina Difa may cause adverse reactions that vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools occurring shortly after dosing.
  • Dizziness: transient feeling of light‑headedness.
  • Headache: mild to moderate pain in the head region.

Serious or Rare Side Effects

  • Severe skin rash: including Stevens‑Johnson syndrome.
  • Hepatic injury: elevated liver enzymes or jaundice.
  • Visual disturbances: blurred vision or optic neuritis.
  • Anaphylaxis: acute allergic reaction requiring emergency care.

Precautions & Warnings

Before prescribing Ivermectina Difa, clinicians should consider several safety aspects.

  • Pregnancy: safety not established; avoid unless benefit outweighs risk.
  • Breastfeeding: unknown safety; assess potential infant exposure.
  • Renal or hepatic impairment: use with caution and monitor function.
  • Drug interactions: review concomitant medications for potential interactions.
  • Pediatric use: caution in children weighing less than 15 kg.
  • Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and light.

Avoid Interactions

Ivermectina Difa can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Warfarin: may increase anticoagulant effect and bleeding risk.
  • Carbamazepine: can reduce ivermectin plasma concentrations.
  • Macrolide antibiotics (e.g., erythromycin): may heighten neurotoxicity.
  • P‑glycoprotein inhibitors (e.g., verapamil): may raise ivermectin levels.

Moderate Interactions (Monitor Closely)

  • Antifungal agents (e.g., ketoconazole): may increase ivermectin exposure.
  • Antiretrovirals (e.g., ritonavir): can alter metabolism and plasma levels.
  • Diuretics: monitor blood pressure and electrolytes during co‑administration.

Frequently Asked Questions

Ivermectina Difa contains ivermectin, an antiparasitic indicated for onchocerciasis, strongyloidiasis, scabies, pediculosis (lice infestation) and a variety of other helminth infections. It is prescribed by qualified health professionals to eliminate the causative parasites and alleviate associated symptoms.

Ivermectin activates glutamate‑gated chloride channels that exist only in invertebrate nerve and muscle cells. This activation causes an influx of chloride ions, leading to hyperpolarization, paralysis, and ultimately death of the parasite, while sparing human cells.

The dosage of Ivermectina Difa is determined by the prescribing clinician based on the specific indication, patient weight, age, and clinical condition. Only a qualified health professional can set the appropriate dose and treatment schedule.

Safety data for ivermectin in pregnancy and lactation are limited. It should be avoided unless the potential benefit justifies the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ivermectin offers a broad‑spectrum antiparasitic effect with a single oral dose for many infections, whereas alternatives such as albendazole or praziquantel may require multiple doses or have a narrower spectrum. Choice of therapy depends on the parasite species, resistance patterns and patient factors.

Ivermectina Difa should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct light. This helps maintain the product’s stability and potency throughout its shelf life.

Ivermectina Difa is taken orally, usually as a single dose or a short course as directed by the prescriber. The tablet should be swallowed with water and taken on an empty stomach unless otherwise instructed.

Serious adverse reactions, though rare, can include severe skin rashes such as Stevens‑Johnson syndrome, hepatic injury, visual disturbances, and anaphylactic reactions. Patients should seek immediate medical attention if they experience any of these symptoms.

Ivermectina Difa is contraindicated in individuals with known hypersensitivity to ivermectin or any excipients in the formulation. Caution is advised for patients with severe hepatic or renal impairment, pregnant women, and children weighing less than 15 kg unless specifically prescribed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ivermectin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT